Monique M.E.M. Bos

Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin

José Baselga, David G. Pfister, Michael R. Cooper et al. · Journal of Clinical Oncology · 2000 · 746 citations

Pharmacy, Oncology, Pharmacology +17

The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy

Clara Klerk, Susanne M. Smorenburg, Hans-Martin Otten et al. · Journal of Clinical Oncology · 2005 · 602 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Validation of 70-gene prognosis signature in node-negative breast cancer

Jolien M. Bueno-de-Mesquita, Sabine C. Linn, Richard Keijzer et al. · Breast Cancer Research and Treatment · 2008 · 176 citations · Full text

Medicine, Bioinformatics, Oncology +14

SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer

Christian Eichelberg, Walter L. Vervenne, Maria De Santis et al. · European Urology · 2015 · 142 citations · Full text

Medicine, Oncology, Pharmacology +16

Intensive care admission of cancer patients: a comparative analysis

Monique M.E.M. Bos, Ilona W. M. Verburg, Ineke Dumaij et al. · Cancer Medicine · 2015 · 110 citations · Full text

Medicine, Oncology, Surgery +12